MENU
CRBU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Caribou Biosciences (CRBU) Earnings Date & Reports
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases... Show more
A.I. Advisor
published Earnings
CRBU is expected to report earnings to rise 22.50% to -29 cents per share on November 10
Q3'26
Est.
$-0.29
Q2'26
Beat
by $0.07
Q1'26
Beat
by $0.07
Q4'25
Beat
by $0.04
Q3'25
Beat
by $0.05
The last earnings report on August 13 showed earnings per share of -23 cents, beating the estimate of -31 cents. With 477.75K shares outstanding, the current market capitalization sits at 131.87M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Industry
N/A
Address
2929 7th Street
Phone
+1 510 982-6030
Employees
97
Web
https://www.cariboubio.com